The EGATIN-TOLIP Survey 2025. A comparison of online and in-person therapy groups in group analytic training as experienced by trainees and trainers
Group Analysis · 17.11.2026
DOI: 10.1177/05333164261501919 ↗Kurz gefasst
Fachartikel in der Zeitschrift Group Analysis, online erschienen am 17.11.2026. Verfasst von Kristian Valbak und 1 weiteren Autor:innen. Die Arbeit nennt 17 Literaturangaben.
Abstract (Originalsprache)
Online group analytic psychotherapy has become a widespread alternative since the 2020 pandemic. Similarly, the use of online therapy in group analytic trainings has proliferated. While prominent colleagues have advocated the use of this setting in training, no research has so far been carried out. The EGATIN (European Group Analytic Training Institutions Network) TOLIP (Training OnLine and In-Person) survey 1 includes responses from 139 trainees and trainers regarding their experiences with both online and in-person personal group analysis during training. This investigation examines the significance of the physical contexts and compares the experienced benefits and preferences across the two modalities. The results are clearly in favour of in-person groups; however, online therapy groups remain a valuable, pragmatic choice.
Zitieren
APA
Valbak, K., & Wotton, L. (2026). The EGATIN-TOLIP Survey 2025. A comparison of online and in-person therapy groups in group analytic training as experienced by trainees and trainers. Group Analysis. https://doi.org/10.1177/05333164261501919
Vancouver
Valbak K, Wotton L. The EGATIN-TOLIP Survey 2025. A comparison of online and in-person therapy groups in group analytic training as experienced by trainees and trainers. Group Analysis. 2026. doi:10.1177/05333164261501919
BibTeX
@article{Valbak2026,
author = {Valbak, Kristian and Wotton, Linde},
title = {The EGATIN-TOLIP Survey 2025. A comparison of online and in-person therapy groups in group analytic training as experienced by trainees and trainers},
journal = {Group Analysis},
year = {2026},
doi = {10.1177/05333164261501919}
}
EUVIMED